Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin + XELOX + Bevacizumab in Metastatic Colorectal Cancer
NCT02026583Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Dec 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in colorectal cancer (CRC), sponsored by Samsung Medical Center. Started Dec 2013; status: completed.
02
Drugs
simvastatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02026583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02026583.